Genome & Company

Contact

Genome & Company
B-8F Silicon Park, 35 Pangyo-ro 255beon-gil, Bundang-gu, Seongnam-si, Gyeonggi-do, Republic of Korea, 13486

Map

Consent to collection and use of personal information (Required)

Genome & Company (the ”Company”) regards the protection of personal information of our users very important, and complies with relevant laws, including the Personal Information Protection Act and the Act on Expansion of Dissemination and Promotion of Utilization of Information System. The Company hereby informs the purpose and method of using the personal information provided by our users through the Company’s website, and what measures are taken to protect the personal information. If the Company revises any of this Private Policy, it will be notified through the notices on the Company’s website (or individually notified).

1. Items of Personal Information Collected and the Collection Method

The Company collects the following personal information to operate its Contact Service via the Company’s website (whereby the users can make general inquires, inquiry for business development, IR inquiry, media inquiry, etc.).
- Essential Information: name, e-mail address, phone number, organization, content of inquiry
- Collection method: The Company collects the personal information through the inquiries submitted via the Contact Bulletin Board on the Company’s website.

  You have the right to refuse the ‘collection of essential information’ as well as the ‘collection of optional information’. If you refuse the collection of essential information, however, you may be restricted for using the Contact Service.

The following information may be automatically generated and collected in the process of using the website.
- IP Address, cookie, date and time of visit, records of service use

2. Purpose of Collecting Personal Information

The Company uses the collected personal information for the following purposes.
- Personal verification, personal identification, delivery of inquiries and notification of results (answers and responses), etc. related to the use of Contact Service

3. Processing of Personal Information and Retention Period

In principle, the collected personal information is destroyed without any delay after achieving the purpose of collecting and using personal information. However, the Company may keep users’ information for a certain period of time as required by relevant laws.
- Retained information: personal information submitted with the inquiry, content of the inquiry, and ensuing responses
- Relevant Law: Act on the Consumer Protection in Electronic Commerce, etc.
- Retention Period: three years (records related to resolution of consumer complaints or disputes)

4. Destruction of Personal Informatio

In principle, the information is destroyed without any delay after achieving the purpose of collecting and using personal information. The procedure and method of destruction are as follows.

1) Procedure
The personal information submitted is transferred to a separate database (in case of paper, separate cabinet) after achieving the purpose and kept for a certain period of time according to the internal policy and other relevant laws, before it is destroyed. The personal information transferred to separate database shall not be used any other purposes other than for keeping in accordance with laws.

  2) Destruction Method
Personal information saved in the form of electronic file shall be deleted by using technical method that cannot reproduce the records. Personal information printed in the paper shall be destroyed by shredding with a shredder or incinerating it.

5. Consignment of Personal Information Processing

The Company does not consign personal information to a third party. If consignment occurs in the future, it shall be notified through website and the contents of this Privacy Policy shall be updated.

6. Rights of Users and Their Legal Representatives

Users and their legal representative (for the users below the age of 14) may make an inquiry related to or request deletion or modification of their own personal information. In this case, please contact the Company’s Data Protection Manager (see Section 7 of this Privacy Policy) in writing, by phone, or by e-mail so that we can take measures without any delay after verifying your identification.

In case users request the correction of any errors in personal information, we shall not use or provide the personal information until such correction is made. In addition, in case incorrect personal information is already provided to a third party, we will notify the third party the result of correction without delay.

The Company processes and destroys personal information at the request of users or their legal representatives in accordance with Section ‘3. Processing of Personal Information and Retention Period’ and Section ‘4. Destruction of Personal Information’, and such information shall not be opened or used for any other purposes.

7. Information on Data Protection Officer and Manager

The Company designates data protection officer and manager for managing personal information as follows to protect users’ personal information related to inquiries.

Data Protection Officer
Name: Seo Yeong-jin
Department: Business management
Position: Vice-president
Telephone: 031-620-0150
Email: youngjin.seo@genomecom.co.kr

  Data Protection Manager
Name: Seol Su-gi
Department: PR team
Position: Team Lead
Telephone: 070-4821-3840
Email: sugi@genomecom.co.kr

You can submit to the personnel above any inquiries related to your personal information submitted to the Company while using our web service. The Company will quickly provide sufficient responses to your inquiries.

Please contact the below agencies if you need report or counseling for any infringement of personal data privacy.

- Personal Information Infringement Report Center (privacy.kisa.or.kr / 118 without area code)
- Personal Information Dispute Mediation Committee (kopico.go.kr / 1833-6972)
- Cyber Investigation Department, Supreme Prosecutor’s Office (www.spo.go.kr / 1301 without area code)
- Cyber Bureau of the National Police Agency (http://cyberbureau.police.go.kr / 182 without area code)

8. Notification

We will notify users any additions, deletions, and modification on the current Privacy Policy in advance through ‘Notice’ on the Company’s website.

9. Other Websites

We inform you that any collection of personal information by other websites which may be hyperlinked on the Company’s website is not the subject of this Privacy Policy.

Dare to Achieve

GENOME & COMPANY

Brave Innovation

We will daringly challenge and succeed in highly marketable and innovative areas, even when they are new and untested.

Trust through Integrity

We strive to present proven results based on solid data and backed by our expertise and conscientious approach

Growth for all

We believe our employees’ talents contribute not only to the growth of the company but also to its social growth.

Scroll Down

Our
Story

About Company
Guided by our belief in the dignity of life, we established Genome & Company in 2015 to contribute to humanity and society through a focus on research and development of microbiome medicine and novel targeted immunotherapy. These unexplored areas carried the risk of uncertainty, but we saw the potential for growth to be as rewarding as the risk.

The boldness to challenge uncertainty without hesitation and the momentum to change uncertainty into certainty constitute the core DNA of Genome & Company.

Genome & Company aims to become a global biotechnology company, driven by the principle that the size of the ambition is proportional to the size of the accomplishment. We set greater goals than any other companies in an area that no one has yet to pioneer. By facing challenge without hesitation and achieving goals that others said were impossible, we have grown into the Genome & Company that exists today.

Genome & Company’s fair and transparent structure of governance supports strict compliance with the law and the highest ethical standards. We remain competitive through acquiring and cultivating exceptional expertise. We achieve world-class results by making balanced investments in research, development and business.

We, Genome & Company, begin our projects by responding to unmet needs in the clinical field. We discover drug candidates by conducting high-quality basic research. Ultimately, we produce successful business outcomes through the excellent clinical development focusing on commercialization.

We fully invest in securing and fostering the best experts in each field encompassing the whole value-chain for balanced development of research, development, and business.
Genome & Company understands that we grow and improve with the growth of our stakeholders, so we do our best to satisfy their needs. We consider customers, internal employees, business partners, shareholders, local community and all humanity as our stakeholders. Genome & Company improves the quality of life for customers by providing innovative new drugs. We promote the growth of our employees through substantial investment in their education and professional development. Moreover, we strive to meet the expectations of business partners and shareholders of Genome & Company by achieving outstanding business results. Ultimately, we believe that these efforts will lead to the creation of desirable values for the local community and all humanity.

Dare to Achieve. 

Genome & Company.

BOLD REALIZATION

Genome & Company endeavors for daring to achieve
and discovering new possibilities in ensuring all people’s right to health.

CORE VALUE

  • BRAVE
    INNOVATION

    Creating possibilities for treatment beyond existing medicines, Genome & Company will continue to pioneer for brave innovations.

  • GROWTH
    FOR ALL

    Genome & Company believes in a core value of creating growth for all through the individuals at Genome & Company aspiring to make positive impacts to the global healthcare community. Genome & Company is committed to providing the necessary means to develop leaders who contribute to our greater community.

  • TRUST
    THROUGH
    INTEGRITY

    Genome & Company believes in building trust through integrity and expertise in our research and development. We will boldly challenge ourselves to bring tangible products.